Yahoo Web Search

  1. and China resume trade talks in Beijing today, with Treasury Secretary Mnuchin and Trade Rep Lighthizer working to re-establish and/or resurrect a trade deal (as President ...

  2. Lilly's Taltz Outshines J&J's Tremfya in Psoriasis Study

    Zacks via Yahoo FinanceAug 14 13:24 PM

    Eli Lilly & Company LLY announced superiority of its plaque psoriasis drug Taltz over J&J’s JNJ new drug, Tremfya (guselkumab), in delivering total skin clearance at week ...

  3. Credit Traders Rush to Hedge as Trade War Whips Bond Market

    Bloomberg via Yahoo FinanceAug 05 19:28 PM

    Blue-chip company bond protection costs rose 5.2 basis points to 61.8 basis points. CDS index trading volumes as of Monday afternoon in New York were about triple typical levels. Bonds ...

  4. Pharma Q2 Earnings Growth Highest: Time to Buy ETFs?

    Zacks via Yahoo FinanceAug 07 14:59 PM

    Revenues grew 10% year over year to $6.27 billion and also trumped the Zacks Consensus Estimate of $6.04 billion. The company lifted its earnings per share guidance to $4.20-$4.30 ...

  5. Pfizer to Combine Off-Patent Drug Business With Mylan

    GuruFocus.com via Yahoo FinanceJul 29 19:05 PM

    and renamed and rebranded upon closing. The deal will be structured as a reverse Morris trust, in which Upjohn will be divested from the New York-based company and ...

  6. Ligand (LGND) Stock Down Despite Q2 Earnings & Sales Beat

    Zacks via Yahoo FinanceJul 31 14:44 PM

    Second-quarter adjusted earnings exclude the impact of non-cash charge of $12.4 million related to Ligand’s investment in Viking Therapeutics, stock-based compensation and non-cash charges ...

  7. Sanofi (SNY) Q2 Earnings Top, Dupixent Shines, EPS View Up

    Zacks via Yahoo FinanceJul 29 14:38 PM

    Sanofi SNY reported second-quarter 2019 earnings of 74 cents per American depositary share, which beat the Zacks Consensus Estimate of 67 cents. Earnings increased 4.8% on a reported basis.

  8. Earnings per share however declined 23% year over year due to lower sales and operating income. Sales declined 8% (down 5% in constant currency terms) year over year. Sales were hurt ...

  9. Today, however, there's a lot of other stuff that might take peoples' eyes away from Fed Chair Jerome Powell and company, including Apple Inc (NASDAQ: AAPL) and Advanced ...

  10. Amgen results beat estimates, lung cancer trial planned

    Reuters via Yahoo FinanceJul 30 20:45 PM

    Amgen also said its experimental cancer drug AMG510 has shown activity in patients with colorectal and appendiceal cancer, helping to boost the company's shares by nearly 3% to ...

  1. Ads
    related to ELI LILLY AND COMPANY